<bill session="111" type="h" number="2855" updated="2013-07-19T23:37:33-04:00">
  <state datetime="2009-06-12">REFERRED</state>
  <status>
    <introduced datetime="2009-06-12"/>
  </status>
  <introduced datetime="2009-06-12"/>
  <titles>
    <title as="introduced" type="short">Drug Overdose Reduction Act</title>
    <title as="introduced" type="official">To reduce deaths occurring from drug overdoses.</title>
  </titles>
  <sponsor id="412263"/>
  <cosponsors>
    <cosponsor id="400013" joined="2009-12-03"/>
    <cosponsor id="400033" joined="2010-06-29"/>
    <cosponsor id="400638" joined="2010-02-26"/>
    <cosponsor id="412258" joined="2010-02-26"/>
    <cosponsor id="400074" joined="2010-05-25"/>
    <cosponsor id="400639" joined="2010-01-26"/>
    <cosponsor id="412236" joined="2010-04-20"/>
    <cosponsor id="400100" joined="2009-07-09"/>
    <cosponsor id="400102" joined="2010-05-11"/>
    <cosponsor id="400140" joined="2010-09-23"/>
    <cosponsor id="412382" joined="2010-09-16"/>
    <cosponsor id="400653" joined="2009-07-31"/>
    <cosponsor id="400162" joined="2009-06-12"/>
    <cosponsor id="400178" joined="2009-06-12"/>
    <cosponsor id="400198" joined="2010-09-23"/>
    <cosponsor id="400230" joined="2009-06-12"/>
    <cosponsor id="400232" joined="2009-12-16"/>
    <cosponsor id="400237" joined="2009-07-09"/>
    <cosponsor id="412293" joined="2010-05-25"/>
    <cosponsor id="400249" joined="2010-04-20"/>
    <cosponsor id="400283" joined="2010-09-23"/>
    <cosponsor id="400290" joined="2009-07-31"/>
    <cosponsor id="400291" joined="2010-09-23"/>
    <cosponsor id="400295" joined="2010-11-29"/>
    <cosponsor id="400301" joined="2010-07-27"/>
    <cosponsor id="412306" joined="2009-06-12"/>
    <cosponsor id="400346" joined="2010-02-26"/>
    <cosponsor id="400350" joined="2010-09-16"/>
    <cosponsor id="400360" joined="2009-12-03"/>
    <cosponsor id="400366" joined="2009-06-12"/>
    <cosponsor id="400407" joined="2010-05-25"/>
    <cosponsor id="400437" joined="2010-09-16"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2009-06-12">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2009-06-15">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Health information and medical records"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary>6/12/2009--Introduced.
Drug Overdose Reduction Act - Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses; and (2) give priority to public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations. Conditions receipt of a grant or agreement on an entity agreeing to use the grant or agreement for: (1) purchasing and distributing drug overdose reversal agents; (2) training first responders, law enforcement and corrections officials, and other individuals in a position to respond to an overdose on the effective response; (3) implementing programs to provide overdose prevention, recognition, treatment, or response to individuals in need; and (4) evaluating, expanding, or replicating such programs. Requires the Director to: (1) compile and publish data, annually, on fatal and nonfatal drug overdoses for the preceding year; (2) award grants to state, local, or tribal governments to improve drug overdose surveillance capabilities; and (3) develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses. Requires the Director of the National Institute on Drug Abuse (NIDA) to: (1) prioritize and conduct or support research on drug overdose and overdose prevention; and (2) support research on dosage forms of naloxone for the prehospital treatment of unintentional drug overdose.</summary>
</bill>
